Vivimed Labs is currently trading at Rs. 443.60, up by 0.80 points or 0.18% from its previous closing of Rs. 442.80 on the BSE.
The scrip opened at Rs. 441.10 and has touched a high and low of Rs. 452.70 and Rs. 436.60 respectively. So far 25515 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 452.40 on 01-Jan-2016 and a 52 week low of Rs. 175.00 on 24-Jun-2015.
Last one week high and low of the scrip stood at Rs. 452.40 and Rs. 425.00 respectively. The current market cap of the company is Rs. 715.07 crore.
The promoters holding in the company stood at 36.99% while Institutions and Non-Institutions held 28.17% and 34.85% respectively.
Vivimed Laboratories has received Competition Commission of India’s (CCI) approval to sell some of its products in its specialty chemicals division to drug firm Clariant Chemicals India. Earlier in September, Vivimed had signed a pact for sale of some products in its specialty chemicals division to Clariant Chemicals India for a consideration of about Rs 380 crore.
Vivimed Labs is a listed company engaged in the business of manufacturing products (active ingredients, formulations, etc) for pharmaceutical, personal care and colour chemistry industry. VLL (Consolidated) has manufacturing facilities in India and Overseas
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1814.50 |
Dr. Reddys Lab | 1340.80 |
Cipla | 1476.45 |
Lupin | 2160.20 |
Zydus Lifesciences | 972.95 |
View more.. |